TickerFacts.

Beta Bionics, Inc. (BBNX): Revenue

Annual figures by period end, from SEC filings.

$100.25M
Year ended 2025-12-31
$119.01M
Trailing 12 months to 2026-06-30
2023-12-31: $11.99M2024-12-31: $65.12M2025-12-31: $100.25M$100.25M
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$100.25M+53.9%2026-02-24, From 2025-01-01
2024-12-31$65.12M+442.9%2026-02-24, From 2024-01-01
2023-12-31$11.99Mn/a2025-03-28, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Beta Bionics, Inc. (BBNX)2025-12-31$100.25M+53.9%
NeuroPace Inc (NPCE)2025-12-31$99.99M+25.1%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$95.13M+59.0%
Pulmonx Corp (LUNG)2025-12-31$90.50M+8.0%
Anika Therapeutics, Inc. (ANIK)2025-12-31$112.82M-5.9%
Orasure Technologies Inc (OSUR)2025-12-31$115.02M-38.1%
Delcath Systems, Inc. (DCTH)2025-12-31$85.23M+129.1%
Iradimed Corp (IRMD)2025-12-31$83.81M+14.4%
TELA Bio, Inc. (TELA)2025-12-31$80.28M+15.8%

Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗